Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Riv Neurol ; 60(3): 125-9, 1990.
Article in Italian | MEDLINE | ID: mdl-2084815

ABSTRACT

This study concerns an analysis of outpatients seen at a Regional Clinic for Extrapyramidal and Cerebellar Disorders during the period 1974-1984. The main findings to emerge from this study are: 1) a predominance of males; 2) peak attendance figures correlated with precise factors; 3) the geographic origin of patients reflected the distance from the Regional Clinic and the relationship between local physicians and physicians at the Regional Clinic. Lastly, this epidemiological study has led to improvements in specific protocols for the management of the long-term outpatient, and to an increase in the number of patients attending the Center.


Subject(s)
Basal Ganglia Diseases/epidemiology , Cerebellar Diseases/epidemiology , Outpatient Clinics, Hospital/statistics & numerical data , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Health Services Accessibility , Humans , Infant , Italy/epidemiology , Male , Middle Aged , Sex Factors
2.
Acta Neurol (Napoli) ; 11(6): 408-14, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2694799

ABSTRACT

Fourteen patients with Parkinson's disease and motor fluctuations were given 125 mg of Madopar HBS or placebo twice a day in addition to their optimal standard Madopar treatment in a double-blind, cross-over study. Clinical response was evaluated by the King's College Hospital Parkinson's Disease Rating Scale, the Mobility in Bed Scale and self-scoring diaries. A significant improvement with the drug was found according to the rating scales, whereas evaluation by self-scoring diaries showed no significant changes. In three patients we observed worsening of abnormal involuntary movements. The present trial suggests that a low dose of Madopar HBS can be useful in addition to levodopa therapy in some patients on long-term treatment.


Subject(s)
Benserazide/therapeutic use , Hydrazines/therapeutic use , Levodopa/therapeutic use , Parkinson Disease, Secondary/drug therapy , Adult , Aged , Clinical Trials as Topic , Double-Blind Method , Drug Combinations/therapeutic use , Female , Humans , Male , Middle Aged , Parkinson Disease, Secondary/physiopathology
3.
Acta Neurol (Napoli) ; 11(4): 239-46, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2801257

ABSTRACT

We report a clinical survey of 82 patients with benign essential tremor (ET). Sixty five patients had a positive family history. Onset age showed two peaks before 20 years and in the sixth decade. Segregation analysis confirmed an autosomal dominant inheritance. Head tremor occurred mainly in aged women, mental symptoms occurred mainly in subjects with a low onset age and a disabling tremor. An early onset age was not related to paternal or maternal transmission. In one family ET was associated with retinitis pigmentosa and ichthyosis.


Subject(s)
Tremor/epidemiology , Adult , Age Factors , Aged , Female , Humans , Male , Middle Aged
4.
Riv Neurol ; 59(2): 83-8, 1989.
Article in Italian | MEDLINE | ID: mdl-2505370

ABSTRACT

Thyrotropin-releasing hormone (TRH) has been reported to improve the clinical picture of patients with the predominantly cerebellar form of spinocerebellar degeneration. The authors performed a double-blind, double cross-over, four-month trial, where TRH, at the daily dose of 2 and 4 mg, and placebo were given intramuscularly over a period of one month each. Sixteen patients with Friedreich's disease and 14 patients with different forms of spinocerebellar degeneration completed the trial. Features of cerebellar involvement, such as dysarthria, dysmetria and stance ataxia, showed a slight but significant improvement during TRH treatment. TRH was well tolerated. Transient nausea was the most frequent side-effect.


Subject(s)
Spinocerebellar Degenerations/drug therapy , Thyrotropin-Releasing Hormone/therapeutic use , Adolescent , Adult , Aged , Double-Blind Method , Female , Friedreich Ataxia/drug therapy , Humans , Injections, Intramuscular , Male , Middle Aged , Thyrotropin-Releasing Hormone/administration & dosage , Thyrotropin-Releasing Hormone/adverse effects
6.
Neurochem Res ; 13(1): 63-7, 1988 Jan.
Article in English | MEDLINE | ID: mdl-3368030

ABSTRACT

A hemagglutinating activity was detected in a synaptic vesicle-enriched fraction prepared from adult rat brain, using trypsinized glutaraldehyde-fixed rabbit erythrocytes. The specific activity of the fraction, in two series of experiments, was 7.5 and 16-fold higher than in the other subcellular fractions. The activity was absent from the synaptosome cytosol. In a study using twenty-five different carbohydrates and glycoproteins, best inhibitors were N-acetylneuraminic acid and N-glycolylneuraminic acid, together with bovine submaxillary mucin and a glycopeptide fraction prepared from rabbit erythrocyte membranes. The activity was thermolabile and very sensitive to proteolytic enzymes (but insensitive to neuraminidase) indicating that a protein (agglutinin) is responsible for the activity. Experiments using detergents and high ionic strength showed that the agglutinin is tightly bound to membranes, inactivated by the so-called non denaturing detergents, and stable in diluted sodium dodecyl sulphate. Hypotheses are discussed on the possible function of the agglutinin.


Subject(s)
Cerebral Cortex/immunology , Hemagglutinins/analysis , Sialic Acids/immunology , Synaptic Vesicles/immunology , Animals , Female , Male , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...